Skip to main content

IN-LICENSING

CSL Seqirus has extensive experience in commercialising pharmaceutical and vaccine products for international partners in Australia and New Zealand. We offer a flexible partnering approach, with an ability to tailor licensing arrangements to meet the needs of our partners. We have a proven track record across a range of therapeutic areas and channels, including GP, specialist and hospital.

Consumer Pain Campaign AU 3

In-licensing for Australia and New Zealand

Our multi-award winning sales and marketing teams are recognised as leaders within the pharmaceutical industry. CSL Seqirus is proud to have high performing primary and specialty care sales teams in Australia and New Zealand. With expertise in both private and reimbursed products, we can help you achieve your commercial goals.

Contact for In-licensing

Find out how CSL Seqirus can help you enter the Australian and or New Zealand market by contacting our team.

Strategic Market Entry

Strategic Market Entry

CSL Seqirus has dedicated regulatory and health economics teams to secure optimum labelling and pricing in Australia and New Zealand markets

Superior Performance

Performance Driven Teams

We have a robust track record building strong brands and achieving rapid market penetration in reimbursed and private markets in Australia and New Zealand.

We make it our own

We Make it Our Own

We make a significant investment and focus our resources during all phases of your product’s lifecycle.

Partnering flexibility

Partnering Flexibility

Our team has a great ability to adapt to our partner’s needs.

AP-CRP-23-0001